[HTML][HTML] Novel treatments for obesity: implications for cancer prevention and treatment

CM Cuttica, IM Briata, A DeCensi - Nutrients, 2023 - mdpi.com
It is now established that obesity is related to a higher incidence of cancer during a lifespan.
The effective treatment of obesity opens up new perspectives in the treatment of a relevant …

[HTML][HTML] Obesity-related cross-talk between prostate cancer and peripheral fat: potential role of exosomes

S Feng, K Lou, C Luo, J Zou, X Zou, G Zhang - Cancers, 2022 - mdpi.com
Simple Summary Obesity is involved in many aspects of prostate cancer progression as a
risk factor for prostate cancer, especially in the process of biochemical recurrence in the …

Healthy lifestyle and prostate cancer risk in the Million Veteran Program

MS Pagadala, A Lui, J Lynch, R Karunamuni, KM Lee… - Cancer, 2022 - Wiley Online Library
Background This study aims to assess the impact of healthy lifestyle on prostate cancer
(PCa) risk in a diverse population. Methods Data for 281,923 men from the Million Veteran …

[HTML][HTML] Obesity and cancer stem cells: roles in cancer initiation, progression and therapy resistance

WJ Xie, J Li - World Journal of Stem Cells, 2023 - ncbi.nlm.nih.gov
Obesity, the global pandemic since industrialization, is the number one lifestyle-related risk
factor for premature death, which increases the incidence and mortality of various diseases …

[HTML][HTML] Recommendations on weight loss and healthy lifestyle in prostate cancer clinical guidelines: A systematic review

M Rivera-Izquierdo, V Martinez-Ruiz… - International Journal of …, 2022 - mdpi.com
Obesity is associated with negative prostate cancer outcomes (eg, specific mortality, all-
cause mortality, biochemical recurrence, etc.), according to the current scientific literature …

Multifaceted impact of adipose conditioned media: Obesity‐driven promotion of prostate cancer and cancer stem cell dynamics

S Erdogan, R Serttas, I Dibirdik… - Cell Biochemistry and …, 2024 - Wiley Online Library
Obesity is an established risk factor for the development and progression of prostate cancer
(PC). This study used adipose conditioned media (ACM) from differentiated adipocytes to …

Treatment intensification with novel hormonal therapy in castration-sensitive prostate cancer: Patient identification and clinical rationale

CN Sternberg, SJ Freedland, DJ George… - Clinical Genitourinary …, 2024 - Elsevier
The clinical rationale for treatment of castration-sensitive prostate cancer (CSPC) with novel
hormonal therapy (NHT) or androgen receptor pathway inhibitor is reviewed. A PubMed …

[HTML][HTML] The Association between Patient Characteristics and Biochemical Recurrence after Radical Prostatectomy

C Siech, M Wenzel, C Lange, C Cano Garcia, C Humke… - Medicina, 2024 - mdpi.com
Background: Biochemical recurrence (BCR) represents the rise of prostate-specific antigen
(PSA) levels after treatment with curative radical prostatectomy (RP) or radiation for prostate …

Does larger prostate size provide protection for cancer specific outcomes in localized prostate cancer

Z Abedali, A Woloshuk, C Cary, RS Boris - The Prostate, 2024 - Wiley Online Library
Objective Benign prostatic hyperplasia is common in the aging population and frequently
comorbid with localized prostate cancer. Large prostate volume places significant …

[HTML][HTML] A healthy diet, a healthy prostate? A brief commentary on the latest research on diet and prostate cancer

GC Galván, JP Daniels, NA Friedrich, S Das… - Prostate cancer and …, 2023 - nature.com
With global estimates of 1.4 million new diagnoses per year, prostate cancer (PC) is the
second most common cancer and the fifth leading cause of death in men [1]. Recognizing …